BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261002T080000
DTEND;TZID=Europe/Stockholm:20261002T170000
DTSTAMP:20260625T101610Z
CREATED:20260316T134245Z
LAST-MODIFIED:20260625T101610Z
UID:10001772-1790928000-1790960400@www.scilifelab.se
SUMMARY:AI Frontiers in Life Sciences: From Models to Meaning
DESCRIPTION:Registration will open soon \n\n\n\nTitle: AI Frontiers in Life Sciences: From Models to Meaning \n\n\n\nDate and time: October 2\, 2026 at 8.00-17.00 CET \n\n\n\nLocation: Humanistiska teatern\, Uppsala\,onsite and livestream via Zoom \n\n\n\nDescription: Please save the date for the upcoming SciLifeLab symposium AI Frontiers in Life Sciences: From Models to Meaning\, taking place October 2\, 2026 in Uppsala. This event will bring together experts in artificial intelligence (AI) and life sciences to discuss emerging directions\, challenges\, and opportunities for AI in life science research. The symposium will include presentations\, demonstrations\, and panel discussions\, with approximately 120 participants onsite and livestream via Zoom. This event is intended for researchers\, infrastructure experts\, and professionals interested in AI-driven life science research. The symposium will serve as an opportunity to gather input to help refine the SciLifeLab AI Strategy and support ongoing and planned work across SciLifeLab. \n\n\n\nFurther details\, including the program and registration\, will be announced soon. \n\n\n\nSpeakers:  \n\n\n\nSebastian Lobentanzer\, Helmholtz Center Munich \nPI Computational Health Center \n\n\n\nSebastian Lobentanzer is a PI at the Computational Health Center at Helmholtz Center Munich since 2025\, and in affiliation with the Open Targets group at the European Bioinformatics Institute (EMBL-EBI) since 2024. Sebastian serves as the head of computational biology at the German Center for Diabetes Research. He is the author of BioCypher – https://biocypher.org/ \, BioChatter – https://biochatter.org/ projects. \n\n\n\nLab Web: https://www.helmholtz-munich.de/en/research-group-lab-9 \n\n\n\n\nAnna Kreshuk\, EMBL\nInterim Head of Unit for CBB \n\n\n\nAnna Kreshuk is a group leader and a Senior Scientist in the Cell Biology and Biophysics Unit at the European Molecular Biology Laboratory (EMBL) in Heidelberg\, Germany. She received a PhD in Computer Science from Heidelberg University in 2012. Following this\, she worked as a PostDoc in the Heidelberg Collaboratory for Image Processing (HCI). She joined EMBL in July 2018\, where her research group develops novel computer vision methods for the analysis of microscopy images. Beyond method development\, she is also committed to the democratisation of machine learning for the life science community\, contributing open source tools such as ilastik and PlantSeg. She is an ELLIS scholar and a scientific co-coordinator of the Horizon Europe project AI4Life. She is Interim Head of Cell Biology and Biophysics Unit since 2024. \n\n\n\nWeb: https://www.embl.org/groups/kreshuk/ \n\n\n\n\nJan Ellenberg\, SciLifeLab\nDirector\, SciLifeLab\,  \n\n\n\nDirector for SciLifeLab & Wallenberg National Program for Data-Driven Life Science \n\n\n\nJan Ellenberg is the director of SciLifeLab\, the national research center for molecular biosciences\, since 2024. He also holds a position as professor of cell biology and biophysics at Karolinska Institutet and as affiliated professor at Stockholm University and KTH. His research focuses on cell division and organization of the cell nucleus. He has recently received support from the Knut and Alice Wallenberg Foundation to launch a new strategic research program at SciLifeLab to create a virtual human cell\, Alpha Cell\, using imaging-based molecular mapping and AI. Web: https://www.scilifelab.se/management/management-group/jan-ellenberg/ \n\n\n\n\n \n\n\n\nFlorian Jug\, Human Technopole\nHead of Computational Biology Research Centre – Multimodal AI Across Scales\, Computational biology\, Research Group Leader\,  \n\n\n\nDr. Florian Jug holds a PhD in Computational Neuroscience from the Institute of Theoretical Computer Science at ETH Zurich. His research aims at pushing the boundary of what AI and machine learning can do to better analyze and quantify biological data. At HT\, Dr. Jug covers the full breadth of bio-image computing\, from research on novel methods for computer vision and machine learning\, all the way to offering bio-image analysis as a service. Web https://humantechnopole.it/en/research-groups/jug-group/ \n\n\n\n\nKadi Liis Saar\, Recursion\nScientific Leader and Associate Principal Scientist\, Recursion\, a company focused on AI-driven solutions in drug discovery. \n\n\n\nDr. Kadi Liis Saar is the Scientific Leader and Associate Principal Scientist\, Computational Biology & Data Science at Recursion\, and elected member of Estonian Young Academy of Science.  Dr. Saar is an interdisciplinary scientist and inventor with a background in chemical engineering and biotechnology (BA & MEng) and biophysical chemistry (PhD University of Cambridge 2018). Previously at Transition Bio\, she was a Junior Research Fellow at St. John’s College\, University of Cambridge and a Schmidt Science Fellow working between the Centre for Misfolding Diseases and the Maxwell Centre 2018-2022. Web: https://www.recursion.com/  \n\n\n\n\nOrganisers: SciLifeLab Data Centre datacentre@scilifelab.se
URL:https://www.scilifelab.se/event/ai-frontiers-in-life-sciences-from-models-to-meaning/
LOCATION:Humanistiska teatern\, Uppsala\, Thunbergsvägen 3C\, Uppsala\, 75238\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Data Centre":MAILTO:datacentre@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261012T120000
DTEND;TZID=Europe/Stockholm:20261014T120000
DTSTAMP:20260507T093008Z
CREATED:20260414T090237Z
LAST-MODIFIED:20260507T093008Z
UID:10001802-1791806400-1791979200@www.scilifelab.se
SUMMARY:WASP-HS & DDLS: Interdisciplinary Workshop
DESCRIPTION:WASP-HS & DDLS: Joint Workshop at Sigtunastiftelsen\, 12–14 October \n\n\n\nThis interdisciplinary workshop brings together a carefully selected group of 25 researchers from diverse fields to exchange perspectives on the ethical\, legal\, and social dimensions of data-intensive research in the life sciences. The conversation is not limited to lawyers and ethicists\, but also includes researchers whose work both shapes and is shaped by these governance frameworks.  \n\n\n\nThe aim is to bring together diverse expertise to explore key challenges\, frame shared research questions\, and spark new interdisciplinary collaborations. \n\n\n\nWorkshop Focus\n\n\n\n→ Analyze governance structures and how they shape data-intensive research in precision medicine\, epidemiology\, infection biology\, biodiversity\, and molecular life sciences→ Identify key legal\, regulatory\, and ethical challenges in data-driven life sciences\, with particular attention to the experiences of scientists working with these issues in practice→ Promote meaningful dialogue across disciplines→ Develop new interdisciplinary research initiatives \n\n\n\nDuration\n\n\n\n12 OctoberArrival and opening from lunch onwards \n\n\n\n13 OctoberFull day of sessions \n\n\n\n14 OctoberClosing and departure ending with lunch  \n\n\n\nExpression of Interest\n\n\n\nApply by May 14 to secure your spot. This workshop is open to researchers from both the WASP-HS and DDLS communities. Spots are limited to 25 participants\, so make sure to fill in the Expression of Interest form to get a chance to attend. \n\n\n\nApply here \n\n\n\nOrganizers\n\n\n\nLianne Colonna\,WASP-HS\, Stockholm UniversityYana Litins’ka\, WASP-HS\, Lund UniversityHeidi Howard\, DDLS\, Chalmers University of TechnologyFrancis Lee\, WASP-HS\, Södertörn UniversityUlrika Wallenquist\, DDLS\, Uppsala UniversityBodil Formark\,WASP-HS\, Södertörn University
URL:https://www.scilifelab.se/event/wasp-hs-ddls-interdisciplinary-workshop/
LOCATION:Sigtunastiftelsen\, Manfred Björkquists allé 4\, Sigtuna\, 193 31\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/11/DDLS.jpg
ORGANIZER;CN="Data-Driven Life Science @ SciLifeLab":MAILTO:ddls@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261013T090000
DTEND;TZID=Europe/Stockholm:20261013T183000
DTSTAMP:20260814T145436Z
CREATED:20251219T143433Z
LAST-MODIFIED:20260814T145436Z
UID:10001690-1791882000-1791916200@www.scilifelab.se
SUMMARY:The PROMISE Initiative: Accelerating Cancer Innovation
DESCRIPTION:This conference focuses on the PROMISE Cancer effort led by Swedish scientists representing Stockholm\, Uppsala\, Umeå\, Linköping\, Lund\, and Gothenburg as well as SciLifeLab. \n\n\n\nThe goal of the conference is to expand the PROMISE Cancer initiative\, promote its efforts\, and continue building the Swedish cancer community. \n\n\n\nAbout PROMISE\n\n\n\nPrecision Omics Initiative Sweden (PROMISE) is a national initiative using genomics and multiomics to understand common diseases\, rare diseases\, and cancer. \n\n\n\nRead more about PROMISE\n\n\n\nProgram and speakers\n\n\n\nCancer encompasses more than 200 distinct diseases\, each with widely varying prognoses\, ranging from highly treatable to aggressive cancers with poor outcomes. Advances in molecular profiling hold great promise for improving diagnostics and treatment by enabling more precise\, personalized approaches tailored to individual patients. Sweden has world-leading cancer registries and high-quality biobanks\, creating unique opportunities for cancer research. By joining forces across the research community\, we can better leverage these national strengths to benefit patients. SciLifeLab platforms support the generation\, integration\, and analysis of data across genomics and a broad range of other omics technologies. \n\n\n\nKeynote\n\n\n\nMike Stratton\, Sanger Institute \n\n\n\nHigh-caliber international and national experts will present on the following main topics: \n\n\n\n\nSingle cell and spatial transcriptomics and multiomics\n\n\n\nCancer genomics\n\n\n\nSingle cell and spatial transcriptomics and multiomics\n\n\n\nGermline cancer risk and liquid biopsies\n\n\n\nFunctional precision cancer medicine\n\n\n\n\nThe PROMISE Initiative_ Accelerating Cancer Innovation_Draft Program.docxDownload\n\n\n\nPoster session\n\n\n\nJunior researchers are encouraged to participate with poster presentations. \n\n\n\nRegistration will open soon. More information will be posted here.\n\n\n\nScientific committee\n\n\n\nKerstin Lindblad-Toh \n\n\n\nProject manager\n\n\n\nAnna Clareborn \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nYou may also be interested in\n\n\n\n\nSciLifeLab Science Summit
URL:https://www.scilifelab.se/event/the-promise-initiative-accelerating-cancer-innovation/
LOCATION:Lecture Hall X\,  University Main Building\, Uppsala\, Biskopsgatan 3\, Uppsala\, 75105\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/12/Promise-Sweden-Banner-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261014T084500
DTEND;TZID=Europe/Stockholm:20261014T170000
DTSTAMP:20260821T150804Z
CREATED:20251219T121224Z
LAST-MODIFIED:20260821T150804Z
UID:10001689-1791967500-1791997200@www.scilifelab.se
SUMMARY:SciLifeLab Science Summit
DESCRIPTION:The Annual Conference SciLifeLab Science Summit is a one-day symposium with a new topic each year. The 2026 topic is: \n\n\n\nCancer Research: Translating Life Science Discoveries to Clinical Breakthroughs\n\n\n\nFor more than a century\, Swedish cancer research has shaped the international scientific landscape\, driven by strong academic environments and a deep societal commitment to transforming discoveries into better treatments. From breakthroughs in cancer genomics and tumor biology to advances in immunology and angiogenesis\, researchers in Sweden continue to push the boundaries of life science and medicine. \n\n\n\nThe SciLifeLab Science Summit brings this legacy into the future by uniting world-leading cancer researchers with cutting-edge technologies across genomics\, proteomics\, imaging\, data science\, and beyond. The summit creates an inspiring forum where scientific excellence meets societal relevance—fostering collaboration\, showcasing groundbreaking research\, and highlighting how cancer research continues to reveal fundamental mechanisms of life while driving innovation with real-world impact. \n\n\n\nThe conference is free of charge. Fika\, lunch and Meet-the-speaker-mingle will be included (only) if you register before deadline on September 21. \n\n\n\nJoin us for a full day of inspiring Science! \n\n\n\nScientific Committee\n\n\n\n\nAnna Dimberg\, Uppsala University (chair)\n\n\n\nPanagiotis Baliakas\, Uppsala University\n\n\n\nGunilla Enblad\, Uppsala University\n\n\n\nCamilla Engblom\, Karolinska Institutet (KI)\n\n\n\nMaréne Landström\, Umeå University\n\n\n\nAris Moustakas\, Uppsala University\n\n\n\nJessica Nordlund\, Uppsala University\n\n\n\nKristian Pietras\, Lund University\n\n\n\nCarina Strell\, Uppsala University and University of Bergen\n\n\n\n\nProject leader: Erika Erkstam\, Operations Office\, SciLifeLab \n\n\n\nRegistration\n\n\n\nDeadline (for registration and posters): September 21 \n\n\n\nRegister here\n\n\n\nQuestions? If you have any inquiries regarding the event or your registration\, please contact events@scilifelab.se \n\n\n\nFor late registrations (after September 21)\, we cannot guarantee lunch\, coffee\, nor can we accommodate any allergies or dietary requirements. These will be subject to availability. We appreciate your understanding. \n\n\n\n\n\n\n\nSpeakers\n\n\n\n\nAngelica Loskog\, Uppsala University\n\n\n\nAnna Martner\, Sahlgrenska Center for Cancer Research\n\n\n\nAri Molofsky\, University of California\, San Francisco\, US.\n\n\n\nBernd Bodenmiller\, University of Zurich and ETH Zurich\, Switzerland\n\n\n\nGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, Belgium\n\n\n\nGunilla Edblad\, Uppsala University and Uppsala University Hospital\n\n\n\nGöran B. Jönsson\, Lund University\n\n\n\nJosé Ignacio Martín-Subero\, Institució Catalana de Recerca i Estudis Avançats (ICREA)\, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)\, Spain\n\n\n\nThoas Fioretos\, Lund University\n\n\n\n\nProf. Angelica Loskog\nUppsala University\, Sweden. \n\n\n\nTitle: Evoking Tumor Immunity in Immune-Resistant Cancers  \n\n\n\nAbstract:  \n\n\n\nGrauers Wiktorin H1\, Lövgren T1\, Wenthe J1\, Ritter A1\, Calandegary A1\, Ekström Ryden V\,1\,2 Hahn A1\,2\, Hamid O3\, Gustafsson Liljefors M4\, Musher BL5\, Brenner MK5\, Ullenhag G1\,2\, Loskog A1\,6. \n\n\n\n1Uppsala University\, Uppsala\, Sweden \n\n\n\n2Uppsala University Hospital\, Uppsala\, Sweden \n\n\n\n3The Angeles Clinic and Research Institute\, A Cedars Sinai Affiliate\, Los Angeles\, CA\, USA \n\n\n\n4Karolinska Hospital\, Huddinge\, Sweden \n\n\n\n4Baylor College of Medicine\, Houston\, TX\, USA \n\n\n\n6Lokon Pharma AB\, Uppsala\, Sweden \n\n\n\nImmunotherapy for cancer is a cornerstone of cancer treatment but despite the initial success\, many patients are either primary resistant or develop resistance during treatment. By engineering the tumor microenvironment using and oncolytic adenoviral gene vector encoding TMZ-CD40L and 4-1BBL (LOAd703)\, we aim to rewire the immunosuppressive state in the patients to drive anti-tumor immune responses allowing for continued immune checkpoint inhibitor (ICI) treatment of refractor patients and/or ICI treatment of indications previously not responding to ICI. LOAd703 plus ICI have been tested in melanoma patients (n=24) refractory to one or several lines of prior ICI\, and in pancreatic cancer patients (LOAd703 +standard chemotherapy\, n=21; LOAd703 + ICI + standard chemotherapy\, n=24) who are commonly not responding to ICI. In these Phase I/II clinical trials blood and biopsies were analyzed for the initiation of immune responses locally in the tumor microenvironment as well as systemically in blood. \n\n\n\nThe treatment was well tolerated with common adverse events related to chemotherapy (pancreatic cancer) or ICI (melanoma and pancreatic cancer). LOAd703 attributed adverse events included fever\, chills\, and cytokine release syndrome\, mostly grade 1 or 2. Both in melanoma and pancreatic cancer\, LOAd703 promoted a typical Th1 type of immune response post treatment initiation which was noted both in the tumor and in blood. Similarly\, tumor responses were noted in both indications as evaluated with Olink proteomics\, NanoString Technology\, and flow cytometry. In conclusion\, LOAd703 can be used together with chemotherapy and/or ICI treatment to rewire the immunosuppressive state in patients towards Th1 immunity and subsequently controlling tumor growth in patients. \n\n\n\n \n\n\n\n \n\n\n\n\nProf. Ari Molofsky\nDepartment of Laboratory Medicine\, University of California\, San Francisco \n\n\n\nTitle: Fibroblast – Immune niches in health and disease. \n\n\n\nBiosketch: Ari Molofsky received a BS with highest honors from the University of Texas at Austin and an MD/PhD with research distinction from the University of Michigan in Ann Arbor. Dr. Molofsky completed residency and fellowship in Clinical Pathology/Hematopathology and now leads a tissue immunology-focused research group in the Department of Laboratory Medicine at UCSF. Dr. Molofsky’s research goals are to understand the regulation and function of tissue-resident immune cells to define novel pathways that can be targeted across diverse human diseases. These tissue-resident immune cells are early organizers of tissue remodeling and first responders during tissue damage and infection\, positioning them as key mediators of tissue health and disease. The Molofsky lab has defined a stromal-immune niche surrounding larger vessels and other border structures in multiple tissues\, including the lungs and brain. They are using 3D quantitative microscopy\, single-cell and spatial transcriptomics\, and cytokine reporters/manipulators to dissect these critical immune-microenvironment interactions\, with a particular focus on bidirectional interactions with fibroblasts. Dr. Molofsky has published papers spanning microbial pathogenesis\, tissue-resident immunity\, and local immune niches. Dr. Molofsky is actively involved in trainee education and teaching and leads the UCSF medical school immunology course. Dr. Molofsky routinely serves as an ad hoc reviewer for multiple journals and is a standing member of the NIH Innate Immunity study section. \n\n\n\nAbstract: \n\n\n\n\nProf. Bernd Bodenmiller\nUniversity of Zurich and ETH Zurich\, Switzerland \n\n\n\nTitle:  \n\n\n\nBiosketch: Bernd Bodenmiller is a quantitative biologist who develops novel experimental and computational approaches for the quantitative analysis of tumor ecosystems to improve our understanding of the mechanisms of tumor development for the benefit of patients. He is the founding director of the Department of Quantitative Biomedicine (DQBM) at the University of Zurich\, which fosters research and education at the interface of biomedical research\, biotechnology\, and computational biology to guide development of next-generation precision medicine. Prof. Bodenmiller obtained his PhD in the group of Ruedi Aebersold at ETH Zürich. For his postdoctoral training\, he joined the laboratory of Garry P. Nolan at Stanford University. In 2012\, he became a group leader and in 2013 an SNF/ERC assistant professor at the University of Zürich. In 2019\, he was tenured and became the founding director of the DQBM. In October 2020 Prof. Bodenmiller has been appointed as Dual Professor for Quantitative Biomedicine at the UZH and at ETH Zurich. His group pioneered the development of imaging mass cytometry\, an approach that enables simultaneously imaging of over 40 proteins and transcripts in tumor tissues (Nat. Methods\, 2014; Cell Systems\, 2017; Nature 2020) and the histoCAT software toolbox (Nat. Methods\, 2017). His groups applies these methods to unravel how cells in the tumor ecosystem drive cancer development to identify mechanisms that might be exploited for therapeutic targeting (Nat. Biotechnology\, 2017\, Cell\, 2017; Cell\, 2019). \n\n\n\n\nProf. Göran Jönsson\nLund University \n\n\n\nTitle: Exploring the role of the anti-tumor immune response in tumor initiation and therapy response in melanoma \n\n\n\nBiosketch: Göran Jönsson is a professor in molecular oncology at Lund University. His research has for many years been based on strong collaboration between basic- and clinician scientists in truly translational projects. Considering this and his background in state-of-the art genomic technologies and applying that on human melanoma tissue puts him in a perfect position to conduct research that will generate groundbreaking findings. This is further substantiated by the group’s publication in Nature (2020). Göran is a faculty member of ESMO (European Society of Medical Oncology) and have an extensive international network. He is frequently invited to large international meetings and acts as a reviewer to several funding agencies and high-impact journals such as Nature. Göran has also been the recipient of Young and Senior Investigator Awards from the Swedish Cancer Society and more recently was awarded with the Göran Gustafsson prize in medicine 2022 from the Royal Swedish Academy of Sciences and Cancer Researcher of the year (2023) from the Swedish Cancer Society. \n\n\n\nAbstract: \n\n\n\n \n\n\n\n\nProf. José Ignacio Martín-Subero\nIDIBAPS\, Spain \n\n\n\nTitle: \n\n\n\nBiosketch: In 2001\, I obtained my PhD in Biochemistry from the University of Navarra on genetics of lymphoid neoplasms under the supervision of Prof. Maria J Calasanz and co-supervision of Prof. Reiner Siebert from the Christian-Albrechts University of Kiel. After that\, I continued my studies on lymphoma genetics as postdoctoral fellow with Prof. Siebert. In 2005\, I became interested in the field of epigenomics and in 2009 I came back to Spain. After a short stay at the IDIBELL\, I went to the UB/IDIBAPS to start my career as independent researcher embedded in the group of Prof. Elias Campo. In 2016\, I was appointed Junior Leader of the Biomedical Epigenomics group at the IDIBAPS and from November 2018 I am ICREA Research Professor at the IDIBAPS. I also have an appointment as associate professor at the UB. Our group is interested in the role of epigenetics in the origin\, evolution and clinical manifestations of lymphoid tumors. \n\n\n\n\nProf. Thoas Fioretos\nLund University \n\n\n\nTitle: From Genomic Discoveries to Better Diagnostics and Therapies in Acute Leukemia \n\n\n\nAbstract: \n\n\n\n \n\n\n\n \n\n\n\n\nProgram\n\n\n\nMore information will follow. \n\n\n\n08:45Registration and coffee\, poster hanging.Please leave large bags and outerwear in the staffed Cloakroom.09:00Doors open. Be seated at 09:1509:15Welcome by SciLifeLab Director Jan Ellenberg09:35Session 1: Immune Niches in CancerModerator: Anna DimbergGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, BelgiumGöran Jönsson\, Lund University\, SwedenFlash Talks10:45Coffee and Poster session (odd numbers)11:25Session 2: Tumor Microenvironment and Clinical TranslationModerator: Carina StrellAri Molofsky\, University of California\, San Francisco (UCSF)\, USAngelica Loskog\, Uppsala University\, SwedenGunilla Enblad\, Uppsala University and Uppsala University Hospital\, Sweden12:45Lunch13:45Session 3: Precision OncologyModerator: Jessica Nordlund & Panagiotis BaliakasJosé Ignacio Martín-Subero\, ICREA-IDIBAPS\, SpainThoas Fioretos\, Lund University\, Sweden14:45Roundtable discussion: What is needed to translate Swedish cancer discoveries into clinical implementation?Moderator: Anna DimbergPanelists: Gunilla Enblad\, Thoas Fioretos\, Maréne Landström\, Angelica Loskog\, Kristian Sandberg.Flash Talks15:15Coffee and Poster session (even numbers)15:55Session 4: Tumor Ecosystems and Spatial BiologyModerator: Aristidis MoustakasBernd Bodenmiller\, University of Zurich and ETH Zurich\, SwitzerlandAnna Martner\, Sahlgrenska Center for Cancer Research\, Sweden16:50Best Poster Award and Closing word; Jan Ellenberg\, Director\, SciLifeLab17:00Meet-the-speaker and network mingle with snacks and beverages18:15End of SciLifeLab Science Summit\n\n\n\n \n\n\n\nPoster session\n\n\n\nEveryone\, especially junior (PhD and postdoc) researchers are encouraged to participate with poster presentations and have the opportunity to win the Best Poster Award. \n\n\n\nDetails about the Poster session\nPoster Presentation Guidelines \n\n\n\nPoster Format \n\n\n\nThe poster boards are 103 cm wide and 143 cm high. \n\n\n\nMount your poster \n\n\n\nThe venue will be open from 8:45 AM. Please proceed to the 6th floor and hang your poster at your designated number. A numbered poster list will be provided closer to the event date. \n\n\n\nPoster sessions \n\n\n\nPoster Session I: During the morning coffee break\, presenters of posters with odd numbers (1\, 3\, 5\, 7…) should be present by their posters. \n\n\n\nPoster Session II: During the afternoon break\, presenters of posters with even numbers (2\, 4\, 6\, 8…) should be present by their posters. \n\n\n\nBest Poster Award \n\n\n\nAll poster presenters should attend the Best Poster Award ceremony at the end of the conference\, where the Best Poster Award will be announced. The Poster Jury will read the abstracts and evaluate the posters throughout the day based on (a) Quality of Science (b) Design (c) Capacity to explain the work. The Poster Jury will select the 2026 Science Summit Best Poster and award the winner a 5\,000 SEK Travel Grant (conditions apply). \n\n\n\nFlash Talks (5-min research pitch) selected from Abstracts. \n\n\n\nThe abstracts will be published on the event website and used to select Flash Talks (5-min research pitch).  \n\n\n\nDismount of posters \n\n\n\nPlease remove your poster immediately after the closing session at 5:00 PM. Poster screens will be collected at 5:30 PM\, and any remaining posters will be discarded. \n\n\n\n\nBest Poster Award\n\n\n\nThe Poster jury\, consisting of SciLifeLab Fellows\, will nominate the Science Summit 2026 Best Poster and award the winner a 5 000 SEK Travel Grant. \n\n\n\nSpread the word – download the flyer\n\n\n\nDigital sign_SS26_qrDownload\n\n\n\n\n\n\n\nPractical information\n\n\n\nTravel to Uppsala\n\n\n\nThe Venue\, Uppsala Konsert & Kongress (UKK) is next to the Train station. MAP here! Travel centres\, bus stops\, parking and hotels are all located within walking distance from Uppsala Konsert & Kongress. Several train and bus lines connect Uppsala to the rest of the country and the region\, and Arlanda Airport is only 18 minutes by train\, Stockholm Central station is approx. 30 minutes by train. \n\n\n\nUppland public transport (UL) timetables and information: www.ul.seStockholm public transport (SL) timetables and information: www.sl.se SJ timestables and information: www.sj.se \n\n\n\nGood to know\, travelling to Uppsala. \n\n\n\nParking\n\n\n\nThe nearest parking garage is Centralgaraget. There is also parking available in Kvarnens parking garage\, Svava\, S:t Per Gallerians garage\, Österplan\, and several other locations in central Uppsala. For more information about parking in the area\, please visit Uppsala Parkering. \n\n\n\nHotels in Uppsala\n\n\n\nFind suggestions for accommodation in Uppsala here \n\n\n\n\nImproved event experience: Introducing the Lyyti Event app \n\n\n\nThis event uses Lyyti for registration. Lyyti has launched the Lyyti Event app\, where you can find your Lyyti registration\, confirmation\, and ticket. You can also edit your information until the registration deadline. \n\n\n\nTo get started\, download “Lyyti Event” and sign up with the same email address you normally use for event registrations. The app only displays events associated with the email address used to create your account. \n\n\n\nIf you register for events using multiple email addresses\, your registrations will be split across separate app accounts. For the best experience\, please use one consistent email address for all Lyyti registrations. We hope this new functionality makes it easier for you to manage your participation. \n\n\n\n\nYou may also be interested in:\n\n\n\n\nThe PROMISE Initiative: Accelerating Cancer Innovation
URL:https://www.scilifelab.se/event/scilifelab-science-summit-2/
LOCATION:Uppsala Konsert & Kongress (UKK)\, Vaksala torg 1\, Uppsala\, 753 31\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/12/Web-banner.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261022T080000
DTEND;TZID=Europe/Stockholm:20261023T170000
DTSTAMP:20260604T095159Z
CREATED:20260604T094520Z
LAST-MODIFIED:20260604T095159Z
UID:10001845-1792656000-1792774800@www.scilifelab.se
SUMMARY:Immunity by Design – In vivo Immune Cell Engineering Conference
DESCRIPTION:Immunity By Design brings together scientists\, clinicians\, and biotech leaders shaping the future of immune cell engineering and immunotherapy. The event will serve as a platform to foster new collaborations across academia\, industry\, and healthcare\, while engaging early career scientists in this fast-moving field. Designed to strengthen Swedish and international research ecosystems\, Immunity By Design will feature breakthroughs in immune engineering\, immune cell therapy\, synthetic immunology\, gene delivery technologies\, and translational research. As in vivo immune engineering rapidly emerges as a transformative cell therapy\, this conference is an exciting opportunity to discuss key findings and ideas for modulating immune responses directly within patients.ORGANIZER: Filipe Pereira\, Lund University; William Nyberg\, Karolinska Institutet; Alexandra Teleki\, Uppsala University \n\n\n\nRead more and Register
URL:https://www.scilifelab.se/event/immunity-by-design-in-vivo-immune-cell-engineering-conference/
LOCATION:Palestra et Odeum\,  Paradisgatan 4\, 223 50 Lund\, Sweden\, Paradisgatan 4\, Lund\, 223 50\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/06/Immunity-by-Design_SciLifeLab-flyer_June26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261022T084500
DTEND;TZID=Europe/Stockholm:20261022T180000
DTSTAMP:20260615T184951Z
CREATED:20260615T184950Z
LAST-MODIFIED:20260615T184951Z
UID:10001848-1792658700-1792692000@www.scilifelab.se
SUMMARY:CBCS 15th Anniversary Symposium
DESCRIPTION:Celebrating 15 years of advancing chemical biology\, drug discovery\, and translational science through cutting-edge technologies and collaborative research. \n\n\n\nDate: October 22\, 2026 \n\n\n\nTime: 08:45-18:00 \n\n\n\nVenue: The Main Auditorium (Stora hörsalen)\, Swedish Museum of Natural History\, Frescativägen 40\, Stockholm \n\n\n\n \n\n\n\nProgram\n\n\n\n15th Anniversary Program_20260603Download\n\n\n\nRegistration\n\n\n\nThe symposium is free of charge. A no-show fee of SEK 2\,000 will apply to registered participants who fail to attend without prior cancellation. Remember to cancel if you can´t come. \n\n\n\nRegister here\n\n\n\nORGANIZER: CBCS \n\n\n\nCONTACT FOR QUESTIONS: Per Moberg\, per.moberg@ki.se
URL:https://www.scilifelab.se/event/cbcs-15th-anniversary-symposium/
LOCATION:Swedish Museum of Natural History\, Frescativägen 40\, Stockholm\, Stockholm\, 114 18\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261027T090000
DTEND;TZID=Europe/Stockholm:20261029T150000
DTSTAMP:20260820T134158Z
CREATED:20260817T093051Z
LAST-MODIFIED:20260820T134158Z
UID:10001858-1793091600-1793286000@www.scilifelab.se
SUMMARY:Exhibition in Navet at BMC\, Uppsala University
DESCRIPTION:October 27-29\, between 09.00-15.00: Don’t miss the chance to discover the latest from30 top life science companies in Sweden and around the world.The entrance to Navet (BMC\, entrance C11) will be open between 09:00-15:00 for external visitors.
URL:https://www.scilifelab.se/event/exhibition-in-navet-at-bmc-uppsala-university-4/
LOCATION:Navet\, SciLifeLab Uppsala\, SciLifeLab Uppsala\, BMC C11\, Husargatan 3\, Uppsala\, 75237\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/08/October_samling_Logos_digital-sign-1-scaled.jpg
ORGANIZER;CN="SciLifeLab Navet":MAILTO:lokalbokning@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261028T083000
DTEND;TZID=Europe/Stockholm:20261030T170000
DTSTAMP:20260728T123422Z
CREATED:20251204T090638Z
LAST-MODIFIED:20260728T123422Z
UID:10001678-1793176200-1793379600@www.scilifelab.se
SUMMARY:Integrating Scales in Planetary Biology
DESCRIPTION:Integrating Scales in Planetary Biology 2026 brings together researchers and stakeholders across disciplines to explore how biological processes — from cells to ecosystems — shape the resilience of life on a changing planet. \n\n\n\nThe conference is designed to foster cross-disciplinary collaboration\, connecting scientists with industry partners\, funders\, and policy-makers to translate knowledge into actionable solutions. \n\n\n\nLed by Planetary Biology at SciLifeLab\, this meeting builds on the momentum of the EMBO workshop “Integrating Cell and Planetary Scales to Address Climate Resilience” (Lisbon\, 2025) and aims to strengthen an emerging international community working at the intersection of molecular biology\, environmental science\, and planetary health. \n\n\n\nHighlights of the programme include:– Scientific talks across disciplines– Round table discussions on emerging research priorities– Pitch Slam session– Panels with funding and policy stakeholders– Dedicated time for networking and collaboration \n\n\n\nInvited speakers \n\n\n\n\nMargaret McFall-Ngai\, Carnegie Science\, US\n\n\n\nAlexandra Worden\, Marine Biological Laboratory\, US\n\n\n\nCorentin Bisot\, AMOLF Institute\, The Netherlands & EMBL\, Germany\n\n\n\nDetlev Arendt\, EMBL\, Germany\n\n\n\nCourtney Stairs\, Uppsala University\, Sweden\n\n\n\nAndrew Haines\, London School of Hygiene & Tropical Medicine\, Centre on  Climate Change and Planetary Health\, UK\n\n\n\nArnau Sebé-Pedrós\, Centre for Genomic Regulation\, Spain & Wellcome Sanger Institute\, UK\n\n\n\nColin Averill\, Funga Public Benefit Corporation\, US\n\n\n\nAnne E. Magurran\, University of St Andrews\, Scotland\n\n\n\nJenni Lehtimäki\, Finnish Environment Institute\, Finland\n\n\n\nFederico Ariel\, IFIBYNE-CONICET\, Argentina\n\n\n\nAnna-Liisa Laine\, University of Helsinki\, Finland\n\n\n\n\nRegister and submit your abstract on the event website \n\n\n\nFor further questions\, reach out to Scientific Coordinator Anabella Aguilera (anabella.aguilera@scilifelab.se) \n\n\n\nEvent website\n\n\n\nPowered By EmbedPress
URL:https://www.scilifelab.se/event/integrating-scales-in-planetary-biology/
LOCATION:Lecture Hall X\,  University Main Building\, Uppsala\, Biskopsgatan 3\, Uppsala\, 75105\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2024/01/PB-conference_-PBwebsite_deadlines_crop2.png
ORGANIZER;CN="SciLifeLab Planetary Biology Strategic Area":MAILTO:anabella.aguilera@scilifelab.se
END:VEVENT
END:VCALENDAR